Alerts will be sent to your verified email
Verify EmailJENBURPH
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Jenburkt Pharmaceuticals Limited, based in India, specializes in manufacturing and marketing pharmaceutical formulations and healthcare products under two divisions: consumer and pharmaceutical. They have a diverse product portfolio with approximately 50 brands promoted through doctors.
Jenburkt Pharma major competitors are Ind-Swift Lab., Medico Remedies, Albert David, Zim Laboratories, Venus Remedies, Lyka Labs, Brooks Laboratories.
Market Cap of Jenburkt Pharma is ₹458 Crs.
While the median market cap of its peers are ₹429 Crs.
Jenburkt Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.